Literature DB >> 1949929

Digoxin assay anomalies due to digoxin-specific Fab immunotherapy.

M Natowicz1, L Shaw.   

Abstract

We demonstrate that digoxin-specific Fab antibody fragments, used in the treatment of severe digitalis intoxication, cause a marked interference with both fluorescence excitation transfer immunoassays and radioimmunoassays for digoxin. In addition, we describe a rapid ultrafiltration method that avoids the Fab-induced interference and affords excellent accuracy and precision. This technique will provide a useful adjunct to the clinical evaluation of patients with digoxin toxicity who are recipients of antidigoxin immunotherapy by enabling a precise determination of their serum digoxin concentrations. By separating the free and protein-bound digoxin this technique also may be useful in evaluating serum digoxin concentrations in patients with abnormal plasma protein concentrations.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1949929     DOI: 10.1177/106002809102500707

Source DB:  PubMed          Journal:  DICP        ISSN: 1042-9611


  2 in total

Review 1.  Therapeutic drug monitoring: antiarrhythmic drugs.

Authors:  T J Campbell; K M Williams
Journal:  Br J Clin Pharmacol       Date:  1998-10       Impact factor: 4.335

Review 2.  Diagnosis and treatment of digoxin toxicity.

Authors:  G Y Lip; M J Metcalfe; F G Dunn
Journal:  Postgrad Med J       Date:  1993-05       Impact factor: 2.401

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.